secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2026-05-01T23:59:59+00:00
Accession:  0001193125-26-201662
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical appoints Cary Vance as permanent CEO, Jan Stern Reed as Board Chair
--------------------------------------------------------------------------------

- Cary Vance named President and CEO effective April 30, 2026; served as Interim CEO since October 2025.
- Jan Stern Reed appointed Chair of the Board; had been Lead Independent Director since October 2025.
- Vance receives $702k base salary, 80% bonus target, and $3.354M in equity awards subject to stockholder approval.
- Employment agreement: 3-year initial term; severance of 18 months base salary plus COBRA if terminated without cause.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/0001193125-26-201662-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000119312526201662/rcel-20260430.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-201662

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer